16
Participants
Start Date
June 22, 2015
Primary Completion Date
September 16, 2016
Study Completion Date
September 16, 2016
GSK1265744 30mg
GSK1265744 30mg tablets are white to almost white coated oval tablets. All subjects will receive GSK1265744 30mg as a single oral dose in the fasted state followed by PK sampling.
GSK Investigational Site, Orlando
GSK Investigational Site, Minneapolis
GSK Investigational Site, Lakewood
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY